Norbert Riedel, Director at Ariad, holds 192.15K shares in Eton Pharmaceuticals (Ticker: ETON), holds 17.65K shares in Jazz Pharmaceuticals (Ticker: JAZZ), holds 0.00 shares in Cerevel Therapeutics Holdings (Ticker: CERE). Most recently, Norbert Riedel Bought ― shares of Eton Pharmaceuticals on Feb 05, 2026 for an estimated value of $132.60K.
Norbert Riedel latest transaction was an Informative Buy of $132.60K.
What was Norbert Riedel's most profitable transaction?
Norbert Riedel’s most profitable transaction was an Informative Buy of ETON stock on February 5, 2026. The return on the trade was 24.90%.
What is Norbert Riedel's role in Ariad?
Norbert Riedel's role in Ariad is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.